Correlation of platelet parameters with adverse maternal and neonatal outcomes in severe preeclampsia: A case-control study

Background: Pre-eclampsia (PET) is a potentially devastating multi-systemic disorder resulting in the generation of oxidative stress. Platelet activation causes vasoconstriction and release of inflammatory cytokines, resulting in an intensified inflammatory response, endothelial damage, and coagulop...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Benjamin S. Umezuluike, Chidebe C. Anikwe, Oluomachi C. Nnachi, Bobbie C.A. Iwe, Chinedu C. Ifemelumma, Ikechukwu B.O. Dimejesi
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/20bd8083e2d14f60aff96d3af133f5bd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:20bd8083e2d14f60aff96d3af133f5bd
record_format dspace
spelling oai:doaj.org-article:20bd8083e2d14f60aff96d3af133f5bd2021-12-02T05:03:24ZCorrelation of platelet parameters with adverse maternal and neonatal outcomes in severe preeclampsia: A case-control study2405-844010.1016/j.heliyon.2021.e08484https://doaj.org/article/20bd8083e2d14f60aff96d3af133f5bd2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2405844021025871https://doaj.org/toc/2405-8440Background: Pre-eclampsia (PET) is a potentially devastating multi-systemic disorder resulting in the generation of oxidative stress. Platelet activation causes vasoconstriction and release of inflammatory cytokines, resulting in an intensified inflammatory response, endothelial damage, and coagulopathy which culminate in adverse pregnancy outcomes. Aim: To compare the platelet parameters between preeclamptic and normotensive pregnant women and their relationship to adverse outcomes in women with pre-eclampsia. Materials and methods: This was a case-control study of platelet indices of 60 pre-eclamptic and 60 normotensive pregnant women recruited at 28 weeks and followed till delivery. A blood sample was collected at entry into the study and just before delivery. The sample was analyzed within 1 h of collection using the Mythic 18 hematological auto-analyzer. Data were analyzed using IBM-SPSS version 22. A P-value of <0.05 was considered statistically significant. Results: The mean platelet count, Platelet distribution width (PDW), plateletcrit were statistically significantly different between normotensive and severe preeclamptic participants (p= <0.001). Statistically significant differences were not present in any of the platelet parameters between mild and severe PET. The odds of developing eclampsia was low at higher mean platelet count and plateletcrit levels above 161.36 ± 73.74 × 109/L [p = 0.02, AOR = 0.27, 95% CI (0.08–0.88)] and 0.13 ± 0.05% [p = 0.001, AOR = 0.22, 95% CI (0.08–0.58)] respectively. Eclampsia was strongly associated with P-LCR (platelet-large cell ratio) above 23.15 ± 4.92% [p = 0.004, AOR = 11.00, 95%CI (1.48–89.02)]. Abruptio placentae had low odds at lower levels of mean plateletcrit. Pre-term birth was significantly lower at mean plateletcrit levels above 0.14 ± 0.05%; admission into neonatal intensive care unit was strongly associated with a mean PLC ratio above 22.73 ± 5.91%. Conclusion: This study demonstrated significant differences in platelet count, plateletcrit, platelet distribution width, and P-LCR between pre-eclamptic and normotensive women. Increase in P-LCR is a risk factor for eclampsia although the effect size is low.Benjamin S. UmezuluikeChidebe C. AnikweOluomachi C. NnachiBobbie C.A. IweChinedu C. IfemelummaIkechukwu B.O. DimejesiElsevierarticlePre-eclampsiaPlatelet parametersAdverse maternal and perinatal outcomesScience (General)Q1-390Social sciences (General)H1-99ENHeliyon, Vol 7, Iss 12, Pp e08484- (2021)
institution DOAJ
collection DOAJ
language EN
topic Pre-eclampsia
Platelet parameters
Adverse maternal and perinatal outcomes
Science (General)
Q1-390
Social sciences (General)
H1-99
spellingShingle Pre-eclampsia
Platelet parameters
Adverse maternal and perinatal outcomes
Science (General)
Q1-390
Social sciences (General)
H1-99
Benjamin S. Umezuluike
Chidebe C. Anikwe
Oluomachi C. Nnachi
Bobbie C.A. Iwe
Chinedu C. Ifemelumma
Ikechukwu B.O. Dimejesi
Correlation of platelet parameters with adverse maternal and neonatal outcomes in severe preeclampsia: A case-control study
description Background: Pre-eclampsia (PET) is a potentially devastating multi-systemic disorder resulting in the generation of oxidative stress. Platelet activation causes vasoconstriction and release of inflammatory cytokines, resulting in an intensified inflammatory response, endothelial damage, and coagulopathy which culminate in adverse pregnancy outcomes. Aim: To compare the platelet parameters between preeclamptic and normotensive pregnant women and their relationship to adverse outcomes in women with pre-eclampsia. Materials and methods: This was a case-control study of platelet indices of 60 pre-eclamptic and 60 normotensive pregnant women recruited at 28 weeks and followed till delivery. A blood sample was collected at entry into the study and just before delivery. The sample was analyzed within 1 h of collection using the Mythic 18 hematological auto-analyzer. Data were analyzed using IBM-SPSS version 22. A P-value of <0.05 was considered statistically significant. Results: The mean platelet count, Platelet distribution width (PDW), plateletcrit were statistically significantly different between normotensive and severe preeclamptic participants (p= <0.001). Statistically significant differences were not present in any of the platelet parameters between mild and severe PET. The odds of developing eclampsia was low at higher mean platelet count and plateletcrit levels above 161.36 ± 73.74 × 109/L [p = 0.02, AOR = 0.27, 95% CI (0.08–0.88)] and 0.13 ± 0.05% [p = 0.001, AOR = 0.22, 95% CI (0.08–0.58)] respectively. Eclampsia was strongly associated with P-LCR (platelet-large cell ratio) above 23.15 ± 4.92% [p = 0.004, AOR = 11.00, 95%CI (1.48–89.02)]. Abruptio placentae had low odds at lower levels of mean plateletcrit. Pre-term birth was significantly lower at mean plateletcrit levels above 0.14 ± 0.05%; admission into neonatal intensive care unit was strongly associated with a mean PLC ratio above 22.73 ± 5.91%. Conclusion: This study demonstrated significant differences in platelet count, plateletcrit, platelet distribution width, and P-LCR between pre-eclamptic and normotensive women. Increase in P-LCR is a risk factor for eclampsia although the effect size is low.
format article
author Benjamin S. Umezuluike
Chidebe C. Anikwe
Oluomachi C. Nnachi
Bobbie C.A. Iwe
Chinedu C. Ifemelumma
Ikechukwu B.O. Dimejesi
author_facet Benjamin S. Umezuluike
Chidebe C. Anikwe
Oluomachi C. Nnachi
Bobbie C.A. Iwe
Chinedu C. Ifemelumma
Ikechukwu B.O. Dimejesi
author_sort Benjamin S. Umezuluike
title Correlation of platelet parameters with adverse maternal and neonatal outcomes in severe preeclampsia: A case-control study
title_short Correlation of platelet parameters with adverse maternal and neonatal outcomes in severe preeclampsia: A case-control study
title_full Correlation of platelet parameters with adverse maternal and neonatal outcomes in severe preeclampsia: A case-control study
title_fullStr Correlation of platelet parameters with adverse maternal and neonatal outcomes in severe preeclampsia: A case-control study
title_full_unstemmed Correlation of platelet parameters with adverse maternal and neonatal outcomes in severe preeclampsia: A case-control study
title_sort correlation of platelet parameters with adverse maternal and neonatal outcomes in severe preeclampsia: a case-control study
publisher Elsevier
publishDate 2021
url https://doaj.org/article/20bd8083e2d14f60aff96d3af133f5bd
work_keys_str_mv AT benjaminsumezuluike correlationofplateletparameterswithadversematernalandneonataloutcomesinseverepreeclampsiaacasecontrolstudy
AT chidebecanikwe correlationofplateletparameterswithadversematernalandneonataloutcomesinseverepreeclampsiaacasecontrolstudy
AT oluomachicnnachi correlationofplateletparameterswithadversematernalandneonataloutcomesinseverepreeclampsiaacasecontrolstudy
AT bobbiecaiwe correlationofplateletparameterswithadversematernalandneonataloutcomesinseverepreeclampsiaacasecontrolstudy
AT chineducifemelumma correlationofplateletparameterswithadversematernalandneonataloutcomesinseverepreeclampsiaacasecontrolstudy
AT ikechukwubodimejesi correlationofplateletparameterswithadversematernalandneonataloutcomesinseverepreeclampsiaacasecontrolstudy
_version_ 1718400696982700032